Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Molecular Insight Pharmaceuticals, Inc. (NASDAQOTCBB:MIPIQ)

CAPS Rating: No stars

A biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

24 Outperform
10 Underperform
 

All-Star Players

5 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:MIPIQ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Justin5342002 (77.56)
Submitted August 12, 2007

The company currently has no drugs on the market which I would imagine no product on the market + expenses = low or declining stock price short term, however,Their two oncology drugs Azedra and Onalta both have orphan drug status which will allow… More

cashsage (99.98)
Submitted November 18, 2009

MIPI has a too high valuation compared to its sales potential. It is also very loss making at least until 2011.

Recent Community Commentary

Read the most recent pitches from players about MIPIQ.

No one has written a Pitch for MIPIQ stock yet. Tell us why you think MIPIQ will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in MIPIQ.

Score Leader

adambward

adambward (57.09) Score: +500.91

The Score Leader is the player with the highest score across all their picks in MIPIQ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
adambward 57.09 6/18/2009 Underperform 3W $6.95 -99.94% +400.97% +500.91 0 Comment
SirCharms 21.13 6/10/2009 Underperform 5Y $4.47 -99.91% +381.13% +481.03 0 Comment
dexxyru 75.44 11/2/2009 Underperform 5Y $4.35 -99.91% +339.07% +438.97 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $4.85 -99.92% +336.58% +436.49 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $4.85 -99.92% +336.58% +436.49 0 Comment
payroll1 82.30 5/12/2008 Underperform 5Y $7.35 -99.94% +238.57% +338.52 0 Comment
sac3 86.14 8/23/2007 Underperform NS $6.90 -99.94% +224.79% +324.73 0 Comment
Styex 64.03 7/31/2007 Underperform NS $8.00 -99.95% +222.63% +322.57 0 Comment
phalayko 85.56 9/28/2007 Underperform 3M $6.82 -99.94% +211.62% +311.56 0 Comment
crossbreed 61.41 7/13/2007 Underperform 1Y $9.12 -99.96% +209.61% +309.56 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MIPIQ.